Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow +4 more
wiley +1 more source
Kaempferol restores the susceptibility of ESBLs Escherichia coli to Ceftiofur
IntroductionThe development of extended-spectrum-beta-lactamase (ESBLs) Escherichia coli (E. coli) has become a global threat to public health. An alternative strategy to alleviate this is identifying potential natural compounds to restore antibiotic ...
Peng-Cheng Li +13 more
doaj +1 more source
ESBL- FROM PETRI DISH TO THE PATIENT
Treatment of extended spectrum beta-lactamase (ESBL) producing strains of Enterobacteriaceae has emerged as a major challenge in hospitalised as well as community based patients. Infections due to ESBL producers range from uncomplicated urinary tract infection to life threatening sepsis.
openaire +2 more sources
Sandip Patil,1,2 Xiaowen Chen,1,2 Ma Lian,2 Feiqiu Wen1,21Department of Haematology and Oncology, Shenzhen Children’s Hospital, Shenzhen, Guangdong Province 518038, People’s Republic of China; 2Paediatric Research Institute, Shenzhen Children&
Patil S, Chen X, Lian M, Wen F
doaj
Public Health Risks of Enterobacterial Isolates Producing Extended-Spectrum β-Lactamases or AmpC β-Lactamases in Food and Food-Producing Animals: An EU Perspective of Epidemiology, Analytical Methods, Risk Factors, and Control Options [PDF]
The blaESBL and blaAmpC genes are spread by plasmid-mediated integrons, insertion sequences, and transposons, some of which are homologous in food animals and humans.
Carattoli, Alessandra +14 more
core
ケンジョウジン ガ ホキン スル キシツ トクイセイ カクチョウガタ β-ラクタマーゼ サンセイ チョウナイ サイキン ノ ケンキュウ [PDF]
This an author's original PDF of an article accepted for publication in Journal of Antimicrobial Chemotherapy. The version of record J. Antimicrob. Chemother. (2012) 67 (7): 1769-1774. is available online at: http://jac.oxfordjournals.org/content/67/
Luvsansharav, Ulzii-Orshikh +1 more
core +1 more source
目的了解我院产超广谱β-内酰胺酶(ESBLs)大肠杆菌、肺炎克雷伯杆菌对临床常用抗生素的耐药情况,为临床治疗和控制ESBLs菌感染提供依据。方法从2003.12005.3我院住院部各科室患者送检的标本中分离出肺炎克雷伯菌和大肠埃希氏菌共229份(同一患者同一菌株只入选一次),其中肺炎克雷伯菌59例,大肠杆菌170例,采用Microscan-walkaway96全自动微生物分析仪NC21板进行细菌鉴定及12种抗菌药物的药敏测定,抑酶剂增强纸片法进行ESBL检测。结果产ESBLs菌56株 ...
孟祥红 +5 more
doaj
目的我院产超广谱β-内酰胺酶(ESBLs)大肠埃希菌的临床分布及耐药性情况,为临床合理用药提供依据。方法采用K-B(Kirby-Bauer)琼脂扩散法做药敏试验,CLSI推荐的筛选和确证试验检测ESBLs。结果共分离出大肠埃希菌163株,ESBLs检出率为65.03%(106/163)。样本分布中以尿液标本检出率最高49.06%(52/106),而科室分布以ICU检出率最高16.98%(18/106)。16种抗生素中,亚胺培南和美罗培南对产ESBLs菌株敏感性最好(100%)。除头孢西丁、美罗培南 ...
张淑芳, 吴多荣
doaj
Presence of extended spectrum β-lactamase producing Escherichia coli in wild geese [PDF]
Butaye, Patrick +6 more
core +1 more source
Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates [PDF]
Objectives This study aimed to: (i) analyse the antibiotic susceptibility testing (AST) profiles of extended spectrum β-lactamase (ESBL)- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates applying EUCAST 2013 AST guidelines; and (ii ...
Bloemberg, Guido V. +2 more
core +1 more source

